Search ))
Medical Technology Law Minnesota

PRACTICES

Medical Technology

DOWNLOAD PDF ))

Medical Technology represents one of the most significant, high-growth technology industries in Minnesota and is a cornerstone of Oppenheimer’s practice. 


Recent Experience
  • Our MedTech client base includes:

 

  • More than 75 MedTech clients—ranging from start-ups to established public companies
  • More than 25 venture-backed, emerging companies
  • Industry leading venture capital firms, including Affinity Capital Management, Split Rock Partners, Thomas, McNerney & Partners, and Vesbridge Partners
  • Our representative experience includes:

 

  • More than 100 private placements of debt and equity for device company clients and venture capital clients in the past five years, with an aggregate deal value in excess of $1 billion
  • Extensive intellectual property counseling in prosecution, strategy, freedom to operate, reexaminations and competitive assessments
  • Complex litigation matters, including employment, “earn out,” distribution and intellectual property disputes
  • Capital raising, public company compliance and mergers and acquisition counseling for middle market, public medical device companies, including American Medical Systems and ev3

Medical Technology Team
Client List
Affinity Capital ManagementAlexandria Research

American Medical Systems

Anulex

Apnex

Arizant

Benechill

BridgePoint

CoAxia

ConcepTx

Denali

Entellus

Envoy

ev3

Hemosphere

Orasi

Sarentis Therapeutics

SetPoint

Spineology

Split Rock

superDimension

Thomas, McNerney & Partners

Torax

Vatrix

Vasamed

Virtual Radiologic

Vesbridge Partners

Ypsomed

 

 

 

 

 

Attorney Contacts
Barbara Wrigley Patrice Kloss 
612.607.7595612.607.7360
MedTech Client Alerts

OIG Issues Special Fraud Alert Calling Physician-Owned Distributors (“PODs”) “Inherently Suspect” Under The Anti-Kickback Statute (3.27.13)

 

Physician Payments Sunshine Final Rule Released (2.18.13)

 

Recent GlaxoSmithKline Global Settlements May Have Far-Reaching Implications for MedTech Companies (7.6.12) 

 

Supreme Court Rules That Sales Representatives Are Exempt From Overtime Pay (7.2.12) 

 

Physician Payments Sunshine Provisions Remain In Effect (6.28.12) 

 

Sunshine Act Data Collection Delayed Until 2013, But Planning For Compliance Should Be Underway Now (5.8.12) 

 

Delay in Regulations Causes Delay in Sunshine Implementation (12.19.11) 

 

Minnesota Angel Investor Tax Credit Amendment Eases Requirements (6.29.11)

 

Impact of Stanford v. Roche Decision On Intellectual Property Transfer and Ownership (6.24.11)

 

FDA Raises Profile of the Responsible Corporate Officer or Park Doctrine (4.18.11)

 

Clinical Trial Sponsors Paying Medical Expenses for Subject Injuries Otherwise Payable by Medicare Must Report to CMS (4.11.11)

 

FDA Announces Changes to Medical Device Review Track (2.1.11)

 

University of Minnesota Adopts New Conflict of Interest Policy For Clinical Health Personnel (8.20.10) 

 

Recent Developments in Fraud and Abuse Law Require Action By Medical Manufacturers (6.2.10) 

 

Additional Guidance For Qualifying Therapeutic Discovery Project Tax Credit/Grant For Medical Technology Companies (5.24.10) 

 

Minnesota Creates Angel Investor Tax Credit and Expands Research & Development Tax Credit (4.12.10) 


Congress Enacts New Investment Tax Credit for Qualified Therapeutic Discovery Projects (4.12.10) 

 

Another Decision Finding Preemption for PMA Medical Device (11.3.09) 

 

New Vermont and Massachusetts Sales and Marketing Requirements Take Effect on July 1, 2009 (6.19.09) 

 

FDA and Health Canada Studying Potential Health Risks of Medical Devices Containing BPA (4.17.09)

 

Wisconsin Supreme Court Finds Product Liability Claims Related to a PMA Medical Device Preempted (2.19.09)  

 

MDL Court Finds All Claims Related to a PMA Medical Device Preempted (1.13.09)  

 

Government Scrutiny of Medical Device Manufacturers' Arrangements With Physicians Highlights Need for Compliance Review (4.21.08) 
All Practice Areas